Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study

Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study

Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined the association between hypothyroidism and dyslipidemia in patients undergoing bexarotene therapy. The aim of this study is...

全面介紹

書目詳細資料
Main Authors: Katsunori Manaka, Junichiro Sato, Yusuke Hikima, Hirofumi Horikoshi, Maho Taguchi, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Reiko Yamashita, Makoto Sugaya, Toshihisa Hamada, Masaomi Nangaku, Taroh Iiri, Noriko Makita
格式: Article
語言:English
出版: The Japan Endocrine Society 2024-08-01
叢編:Endocrine Journal
主題:
bexarotene
hypothyroidism
dyslipidemia
hypertriglyceridemia
在線閱讀:https://www.jstage.jst.go.jp/article/endocrj/71/8/71_EJ23-0699/_html/-char/en

因特網

https://www.jstage.jst.go.jp/article/endocrj/71/8/71_EJ23-0699/_html/-char/en

相似書籍